The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1.
Whitson JT, Ochsner KI, Moster MR, Sullivan EK, Andrew RM, Silver LH, Wells DT, James JE, Bosworth CF, Dickerson JE, Landry TA, Bergamini MV; Brimonidine 0.15% Study Group.
Whitson JT, et al. Among authors: bosworth cf.
Ophthalmology. 2006 Aug;113(8):1333-9. doi: 10.1016/j.ophtha.2006.03.025.
Ophthalmology. 2006.
PMID: 16877072
Clinical Trial.